More about West Pharmaceutical Services, Inc.
Regulatory Filings for West Pharmaceutical Services, Inc.
Fundamentals for West Pharmaceutical Services, Inc.
From AI Euphoria to Energy Fear: The Market‘s Pivot as Middle East Conflict Reshapes Portfolios
From AI Adoption Surge to Capex Scrutiny: Volatility Risks Loom for U.S. Financial Markets
Airlines and Tourism Stocks Face Pressure as Global Risks Escalate
Technicals for West Pharmaceutical Services, Inc.
Price Summary
On 2026-03-13, West Pharmaceutical Services, Inc.'s stock began at 234.58, peaked at 237.2, declined to 231.43, and ended the day 0.38% higher at 235.46, with 766400 shares traded.The peak price for the stock in the past 52 weeks is 307.25, with the lowest price being 190.39.
Technicals
Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
Bol. Bands: The BOLL BANDS is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
Parabolic SAR: The PSAR continues its bearish trend for West Pharmaceutical Services, Inc., setting a resistance level that could hinder upward momentum. This resistance suggests that the market may face challenges in breaking higher, reflecting persistent bearish sentiment.
Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
Tripple Moving Agerage: The moving averages for the 20-50-100 periods indicate a bullish trend, though the slopes of the faster averages suggest that this trend may not last. The weakening signals from the shorter-term averages point to a potential reversal, indicating that the current upward momentum could be approaching a turning point.
Understanding a company's fundamentals—such as revenue, earnings, and debt levels—provides a solid foundation for analyzing its technical performance. Similarly, knowledge of the industry, including key competitors and market trends, is critical. Combining this fundamental analysis with technical indicators like stock charts, moving averages, and trading volume enables a more comprehensive approach to evaluating the company's overall health and potential future performance.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst technicals.
Latest Regulatory Filings for SP5
Companies with the best and the worst fundamentals.
Retailers at a Crossroads: Analyzing the Shift to Value in January Sales
Corporate Governance in the Crosshairs: SEC Policy Shifts and the Litigation Wave